Avinger Revenue and Competitors
Estimated Revenue & Valuation
- Avinger's estimated annual revenue is currently $25.1M per year.
- Avinger's estimated revenue per employee is $251,000
- Avinger's total funding is $226.9M.
Employee Data
- Avinger has 100 Employees.
- Avinger grew their employee count by -6% last year.
Avinger Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Avinger?
Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company?s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger?s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.
keywords:N/A
$226.9M
Total Funding
100
Number of Employees
$25.1M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avinger's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology Officer | Reveal Email/Phone |
2 | Compliance Lead | Reveal Email/Phone |
3 | President and CEO | Reveal Email/Phone |
4 | Territory Sales Manager | Reveal Email/Phone |
5 | Clinical Specialist | Reveal Email/Phone |
6 | Territory Sales Manager | Reveal Email/Phone |
7 | Area Sales Manager | Reveal Email/Phone |
8 | Director Sales - Southern U.S. | Reveal Email/Phone |
9 | Production Packaging and Capital Equip Lead | Reveal Email/Phone |
10 | VP, Quality | Reveal Email/Phone |
Avinger News
Avinger (NASDAQ:AVGR) vs. InspireMD (NYSE:NSPR) Financial Survey. Posted by admin on Apr 23rd, 2022. Share on Twitter Share on Facebook Share on LinkedIn...
Avinger received 510(k) clearance for the Lightbox 3 from the U.S. Food & Drug Administration (FDA) in January, and conducted a successful...
Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the...
Avinger closed out a feverish medtech IPO season with by registering for a $69 million initial public offering in the waning days of 2014. Redwood City, Calif.-based Avinger, which makes a family of vascular catheters aimed at the peripheral vascular market, filed Dec. 30 with the FDA for the o ...
Avinger, Inc., a Redwood City, Calif.-based producer of therapeutic devices incorporating intravascular imaging, closed a funding round of undisclosed amount. The company intends to use the funds for commercial growth of lumivascular platform and enrollment of the a US pivotal study demonstrati ...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.7M | 101 | 1% | $198.5M |
#2 | $21M | 104 | -4% | N/A |
#3 | $21.4M | 105 | 14% | $19.9M |
#4 | $15.2M | 105 | 2% | $24.2M |
#5 | $18.7M | 107 | 10% | N/A |